Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra T van Tiel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The British Journal of Radiology|August 8, 2015
Nanoparticles and clinically applicable cell trackingMonique R Bernsen, Jamal Guenoun, Sandra T van Tiel, et al.
Anticancer Research|May 5, 2005
Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing ratsSaske Hoving, Sandra T van Tiel, Alexander M M Eggermont, et al.
European Radiology|August 13, 2009
Labelling of mammalian cells for visualisation by MRIMonique R Bernsen, Amber D Moelker, Piotr A Wielopolski, et al.
Contrast Media & Molecular Imaging|October 26, 2010
Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cellsSandra T van Tiel, Piotr A Wielopolski, Gavin C Houston, et al.
Anticancer Research|August 28, 2004
Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcomaBoudewijn Van Etten, Sandra T Van Tiel, Gisela Ambagtsheer, et al.
Contrast Media & Molecular Imaging|March 22, 2012
Cell quantification: evolution of compartmentalization and distribution of iron-oxide particles and labeled cellsGyula Kotek, Sandra T van Tiel, Piotr A Wielopolski, et al.
Anti-Cancer Drugs|June 3, 2005
Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing ratsSaske Hoving, Ann L B Seynhaeve, Sandra T van Tiel, et al.
International Journal of Cancer|January 5, 2002
Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing ratsTimo L M ten Hagen, Ann L B Seynhaeve, Sandra T van Tiel, et al.
Plos One|September 21, 2018
SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressuresIlya Skachkov, Ying Luan, Sandra T van Tiel, et al.
Annals of Surgical Oncology|November 11, 2006
Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastasesFlavia Brunstein, Alexander M M Eggermont, Gisela aan de Wiel-Ambagtsheer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The British Journal of Radiology|August 8, 2015
Nanoparticles and clinically applicable cell trackingMonique R Bernsen, Jamal Guenoun, Sandra T van Tiel, et al.
Anticancer Research|May 5, 2005
Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing ratsSaske Hoving, Sandra T van Tiel, Alexander M M Eggermont, et al.
European Radiology|August 13, 2009
Labelling of mammalian cells for visualisation by MRIMonique R Bernsen, Amber D Moelker, Piotr A Wielopolski, et al.
Contrast Media & Molecular Imaging|October 26, 2010
Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cellsSandra T van Tiel, Piotr A Wielopolski, Gavin C Houston, et al.
Anticancer Research|August 28, 2004
Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcomaBoudewijn Van Etten, Sandra T Van Tiel, Gisela Ambagtsheer, et al.
Contrast Media & Molecular Imaging|March 22, 2012
Cell quantification: evolution of compartmentalization and distribution of iron-oxide particles and labeled cellsGyula Kotek, Sandra T van Tiel, Piotr A Wielopolski, et al.
Anti-Cancer Drugs|June 3, 2005
Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing ratsSaske Hoving, Ann L B Seynhaeve, Sandra T van Tiel, et al.
International Journal of Cancer|January 5, 2002
Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil) in soft tissue sarcoma-bearing ratsTimo L M ten Hagen, Ann L B Seynhaeve, Sandra T van Tiel, et al.
Plos One|September 21, 2018
SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressuresIlya Skachkov, Ying Luan, Sandra T van Tiel, et al.
Annals of Surgical Oncology|November 11, 2006
Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastasesFlavia Brunstein, Alexander M M Eggermont, Gisela aan de Wiel-Ambagtsheer, et al.
Pageof 3